News
4d
Zacks Investment Research on MSNRoche Gets Nod for Expanded Use of Columvi in Lymphoma in EuropeRoche RHHBY announced that the European Commission has approved its lymphoma drug, Columvi (glofitamab), for second-line ...
4d
Pharmaceutical Technology on MSNRoche’s Columvi combo gains EC approval for DLBCLRoche has secured approval from the European Commission (EC) for Columvi (glofitamab) plus gemcitabine and oxaliplatin (GemOx ...
Roche (RHHBY) announced that the European Commission, EC, has approved Columvi in combination with gemcitabine and oxaliplatin for the ...
Bristol Myers Squibb has received the FDA’s green light to introduce another immunotherapy-based treatment in first-line ...
The moment every 1923 fan has been waiting for has finally arrived. In this week’s episode, Father Renaud (Sebastian Roché) finally catches up with Teonna Rainwater (Aminah Nieves). After ...
The LINE Messaging API SDK for Java makes it easy to develop bots using LINE Messaging API, and you can create a sample bot within minutes. Note: You don't need to use an add-on like Fixie to have ...
In a less buoyant market environment for furnishings and with high comparison base in 2023 (year at a record) , Roche Bobois SA reports resilient annual results in line with expectations.
Delhi HC denies interim injunction on Roche rare disease drug, opening the door for generic versions
Patients with Spinal Muscular Atrophy (SMA) are hopeful of getting access to generic versions of Roche’s patented drug Risdiplam, following Delhi High Court’s denial of an interim injunction ...
The Delhi High Court on Monday dismissed an interim injunction application filed by Swiss pharmaceutical giant F Hoffmann-La Roche AG against Indian drugmaker Natco Pharma Limited alleging that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results